CN112662655B - Cephalosporin C acylase mutant and preparation method and application thereof - Google Patents
Cephalosporin C acylase mutant and preparation method and application thereof Download PDFInfo
- Publication number
- CN112662655B CN112662655B CN202011591118.8A CN202011591118A CN112662655B CN 112662655 B CN112662655 B CN 112662655B CN 202011591118 A CN202011591118 A CN 202011591118A CN 112662655 B CN112662655 B CN 112662655B
- Authority
- CN
- China
- Prior art keywords
- ala
- gly
- pro
- leu
- asp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 title claims abstract description 89
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 30
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 claims abstract description 19
- 150000001413 amino acids Chemical group 0.000 claims abstract description 14
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract description 8
- 239000013612 plasmid Substances 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- 230000006698 induction Effects 0.000 claims description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 238000010367 cloning Methods 0.000 claims description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 3
- 239000013600 plasmid vector Substances 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 33
- 108090000790 Enzymes Proteins 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 20
- 230000035772 mutation Effects 0.000 abstract description 13
- 108010034416 glutarylamidocephalosporanic acid acylase Proteins 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000006467 substitution reaction Methods 0.000 abstract description 3
- 239000004475 Arginine Substances 0.000 abstract description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 2
- 229930182817 methionine Natural products 0.000 abstract description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract description 2
- 150000003839 salts Chemical class 0.000 abstract description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract description 2
- HOKIDJSKDBPKTQ-GLXFQSAKSA-M cephalosporin C(1-) Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-M 0.000 abstract 2
- 108700023418 Amidases Proteins 0.000 description 41
- 102000005922 amidase Human genes 0.000 description 41
- 238000006243 chemical reaction Methods 0.000 description 10
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 8
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 229930024421 Adenine Natural products 0.000 description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- FEZJJKXNPSEYEV-CIUDSAMLSA-N Arg-Gln-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O FEZJJKXNPSEYEV-CIUDSAMLSA-N 0.000 description 4
- KESWRFKUZRUTAH-FXQIFTODSA-N Asp-Pro-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O KESWRFKUZRUTAH-FXQIFTODSA-N 0.000 description 4
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 4
- 229960000643 adenine Drugs 0.000 description 4
- 108010008355 arginyl-glutamine Proteins 0.000 description 4
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 4
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 4
- 108010092854 aspartyllysine Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 108010049041 glutamylalanine Proteins 0.000 description 4
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 4
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 229940113082 thymine Drugs 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000638501 Pseudomonas sp. GK16 Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 229940104302 cytosine Drugs 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 238000012257 pre-denaturation Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- LIWOHUSRWUWRSX-ZJZGAYNASA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoic acid Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 LIWOHUSRWUWRSX-ZJZGAYNASA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 2
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 2
- IMMKUCQIKKXKNP-DCAQKATOSA-N Ala-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCN=C(N)N IMMKUCQIKKXKNP-DCAQKATOSA-N 0.000 description 2
- GORKKVHIBWAQHM-GCJQMDKQSA-N Ala-Asn-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GORKKVHIBWAQHM-GCJQMDKQSA-N 0.000 description 2
- PBAMJJXWDQXOJA-FXQIFTODSA-N Ala-Asp-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PBAMJJXWDQXOJA-FXQIFTODSA-N 0.000 description 2
- MKZCBYZBCINNJN-DLOVCJGASA-N Ala-Asp-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MKZCBYZBCINNJN-DLOVCJGASA-N 0.000 description 2
- IKKVASZHTMKJIR-ZKWXMUAHSA-N Ala-Asp-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IKKVASZHTMKJIR-ZKWXMUAHSA-N 0.000 description 2
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 2
- ZPXCNXMJEZKRLU-LSJOCFKGSA-N Ala-His-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CN=CN1 ZPXCNXMJEZKRLU-LSJOCFKGSA-N 0.000 description 2
- KMGOBAQSCKTBGD-DLOVCJGASA-N Ala-His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CN=CN1 KMGOBAQSCKTBGD-DLOVCJGASA-N 0.000 description 2
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 2
- WUHJHHGYVVJMQE-BJDJZHNGSA-N Ala-Leu-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WUHJHHGYVVJMQE-BJDJZHNGSA-N 0.000 description 2
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 2
- XRUJOVRWNMBAAA-NHCYSSNCSA-N Ala-Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 XRUJOVRWNMBAAA-NHCYSSNCSA-N 0.000 description 2
- CJQAEJMHBAOQHA-DLOVCJGASA-N Ala-Phe-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CJQAEJMHBAOQHA-DLOVCJGASA-N 0.000 description 2
- DXTYEWAQOXYRHZ-KKXDTOCCSA-N Ala-Phe-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N DXTYEWAQOXYRHZ-KKXDTOCCSA-N 0.000 description 2
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 2
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 2
- VJVQKGYHIZPSNS-FXQIFTODSA-N Ala-Ser-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N VJVQKGYHIZPSNS-FXQIFTODSA-N 0.000 description 2
- NZGRHTKZFSVPAN-BIIVOSGPSA-N Ala-Ser-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N NZGRHTKZFSVPAN-BIIVOSGPSA-N 0.000 description 2
- AENHOIXXHKNIQL-AUTRQRHGSA-N Ala-Tyr-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]([NH3+])C)CC1=CC=C(O)C=C1 AENHOIXXHKNIQL-AUTRQRHGSA-N 0.000 description 2
- XAXMJQUMRJAFCH-CQDKDKBSSA-N Ala-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 XAXMJQUMRJAFCH-CQDKDKBSSA-N 0.000 description 2
- XKHLBBQNPSOGPI-GUBZILKMSA-N Ala-Val-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)N XKHLBBQNPSOGPI-GUBZILKMSA-N 0.000 description 2
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 2
- NKBQZKVMKJJDLX-SRVKXCTJSA-N Arg-Glu-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NKBQZKVMKJJDLX-SRVKXCTJSA-N 0.000 description 2
- HIMXTOIXVXWHTB-DCAQKATOSA-N Arg-Met-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N HIMXTOIXVXWHTB-DCAQKATOSA-N 0.000 description 2
- RATVAFHGEFAWDH-JYJNAYRXSA-N Arg-Phe-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCN=C(N)N)N RATVAFHGEFAWDH-JYJNAYRXSA-N 0.000 description 2
- YFHATWYGAAXQCF-JYJNAYRXSA-N Arg-Pro-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YFHATWYGAAXQCF-JYJNAYRXSA-N 0.000 description 2
- AMIQZQAAYGYKOP-FXQIFTODSA-N Arg-Ser-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O AMIQZQAAYGYKOP-FXQIFTODSA-N 0.000 description 2
- LFAUVOXPCGJKTB-DCAQKATOSA-N Arg-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N LFAUVOXPCGJKTB-DCAQKATOSA-N 0.000 description 2
- ZDOQDYFZNGASEY-BIIVOSGPSA-N Asn-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N)C(=O)O ZDOQDYFZNGASEY-BIIVOSGPSA-N 0.000 description 2
- IYVSIZAXNLOKFQ-BYULHYEWSA-N Asn-Asp-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IYVSIZAXNLOKFQ-BYULHYEWSA-N 0.000 description 2
- OOWSBIOUKIUWLO-RCOVLWMOSA-N Asn-Gly-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O OOWSBIOUKIUWLO-RCOVLWMOSA-N 0.000 description 2
- BXUHCIXDSWRSBS-CIUDSAMLSA-N Asn-Leu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BXUHCIXDSWRSBS-CIUDSAMLSA-N 0.000 description 2
- RVHGJNGNKGDCPX-KKUMJFAQSA-N Asn-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N RVHGJNGNKGDCPX-KKUMJFAQSA-N 0.000 description 2
- GFGUPLIETCNQGF-DCAQKATOSA-N Asn-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O GFGUPLIETCNQGF-DCAQKATOSA-N 0.000 description 2
- OOXUBGLNDRGOKT-FXQIFTODSA-N Asn-Ser-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OOXUBGLNDRGOKT-FXQIFTODSA-N 0.000 description 2
- BCADFFUQHIMQAA-KKHAAJSZSA-N Asn-Thr-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BCADFFUQHIMQAA-KKHAAJSZSA-N 0.000 description 2
- GHWWTICYPDKPTE-NGZCFLSTSA-N Asn-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N GHWWTICYPDKPTE-NGZCFLSTSA-N 0.000 description 2
- WSOKZUVWBXVJHX-CIUDSAMLSA-N Asp-Arg-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O WSOKZUVWBXVJHX-CIUDSAMLSA-N 0.000 description 2
- SBHUBSDEZQFJHJ-CIUDSAMLSA-N Asp-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O SBHUBSDEZQFJHJ-CIUDSAMLSA-N 0.000 description 2
- VHQOCWWKXIOAQI-WDSKDSINSA-N Asp-Gln-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O VHQOCWWKXIOAQI-WDSKDSINSA-N 0.000 description 2
- HAFCJCDJGIOYPW-WDSKDSINSA-N Asp-Gly-Gln Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O HAFCJCDJGIOYPW-WDSKDSINSA-N 0.000 description 2
- SVABRQFIHCSNCI-FOHZUACHSA-N Asp-Gly-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SVABRQFIHCSNCI-FOHZUACHSA-N 0.000 description 2
- KTTCQQNRRLCIBC-GHCJXIJMSA-N Asp-Ile-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O KTTCQQNRRLCIBC-GHCJXIJMSA-N 0.000 description 2
- JNNVNVRBYUJYGS-CIUDSAMLSA-N Asp-Leu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O JNNVNVRBYUJYGS-CIUDSAMLSA-N 0.000 description 2
- RQHLMGCXCZUOGT-ZPFDUUQYSA-N Asp-Leu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RQHLMGCXCZUOGT-ZPFDUUQYSA-N 0.000 description 2
- IVPNEDNYYYFAGI-GARJFASQSA-N Asp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N IVPNEDNYYYFAGI-GARJFASQSA-N 0.000 description 2
- VWWAFGHMPWBKEP-GMOBBJLQSA-N Asp-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)N VWWAFGHMPWBKEP-GMOBBJLQSA-N 0.000 description 2
- PWAIZUBWHRHYKS-MELADBBJSA-N Asp-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)O)N)C(=O)O PWAIZUBWHRHYKS-MELADBBJSA-N 0.000 description 2
- BKOIIURTQAJHAT-GUBZILKMSA-N Asp-Pro-Pro Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 BKOIIURTQAJHAT-GUBZILKMSA-N 0.000 description 2
- KNDCWFXCFKSEBM-AVGNSLFASA-N Asp-Tyr-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KNDCWFXCFKSEBM-AVGNSLFASA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- YJIUYQKQBBQYHZ-ACZMJKKPSA-N Gln-Ala-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YJIUYQKQBBQYHZ-ACZMJKKPSA-N 0.000 description 2
- HHWQMFIGMMOVFK-WDSKDSINSA-N Gln-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O HHWQMFIGMMOVFK-WDSKDSINSA-N 0.000 description 2
- KJRXLVZYJJLUCV-DCAQKATOSA-N Gln-Arg-Met Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O KJRXLVZYJJLUCV-DCAQKATOSA-N 0.000 description 2
- RMOCFPBLHAOTDU-ACZMJKKPSA-N Gln-Asn-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RMOCFPBLHAOTDU-ACZMJKKPSA-N 0.000 description 2
- WQWMZOIPXWSZNE-WDSKDSINSA-N Gln-Asp-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O WQWMZOIPXWSZNE-WDSKDSINSA-N 0.000 description 2
- CITDWMLWXNUQKD-FXQIFTODSA-N Gln-Gln-Asn Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CITDWMLWXNUQKD-FXQIFTODSA-N 0.000 description 2
- QFJPFPCSXOXMKI-BPUTZDHNSA-N Gln-Gln-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N QFJPFPCSXOXMKI-BPUTZDHNSA-N 0.000 description 2
- FQCILXROGNOZON-YUMQZZPRSA-N Gln-Pro-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O FQCILXROGNOZON-YUMQZZPRSA-N 0.000 description 2
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 2
- AVZHGSCDKIQZPQ-CIUDSAMLSA-N Glu-Arg-Ala Chemical compound C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AVZHGSCDKIQZPQ-CIUDSAMLSA-N 0.000 description 2
- CKRUHITYRFNUKW-WDSKDSINSA-N Glu-Asn-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CKRUHITYRFNUKW-WDSKDSINSA-N 0.000 description 2
- VFZIDQZAEBORGY-GLLZPBPUSA-N Glu-Gln-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VFZIDQZAEBORGY-GLLZPBPUSA-N 0.000 description 2
- HTTSBEBKVNEDFE-AUTRQRHGSA-N Glu-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N HTTSBEBKVNEDFE-AUTRQRHGSA-N 0.000 description 2
- QIQABBIDHGQXGA-ZPFDUUQYSA-N Glu-Ile-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QIQABBIDHGQXGA-ZPFDUUQYSA-N 0.000 description 2
- QXDXIXFSFHUYAX-MNXVOIDGSA-N Glu-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O QXDXIXFSFHUYAX-MNXVOIDGSA-N 0.000 description 2
- DDXZHOHEABQXSE-NKIYYHGXSA-N Glu-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O DDXZHOHEABQXSE-NKIYYHGXSA-N 0.000 description 2
- MLILEEIVMRUYBX-NHCYSSNCSA-N Glu-Val-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O MLILEEIVMRUYBX-NHCYSSNCSA-N 0.000 description 2
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 2
- MFVQGXGQRIXBPK-WDSKDSINSA-N Gly-Ala-Glu Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFVQGXGQRIXBPK-WDSKDSINSA-N 0.000 description 2
- DTPOVRRYXPJJAZ-FJXKBIBVSA-N Gly-Arg-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N DTPOVRRYXPJJAZ-FJXKBIBVSA-N 0.000 description 2
- UXJHNZODTMHWRD-WHFBIAKZSA-N Gly-Asn-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O UXJHNZODTMHWRD-WHFBIAKZSA-N 0.000 description 2
- XQHSBNVACKQWAV-WHFBIAKZSA-N Gly-Asp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XQHSBNVACKQWAV-WHFBIAKZSA-N 0.000 description 2
- MBOAPAXLTUSMQI-JHEQGTHGSA-N Gly-Glu-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MBOAPAXLTUSMQI-JHEQGTHGSA-N 0.000 description 2
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 2
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 2
- FJWSJWACLMTDMI-WPRPVWTQSA-N Gly-Met-Val Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O FJWSJWACLMTDMI-WPRPVWTQSA-N 0.000 description 2
- VDCRBJACQKOSMS-JSGCOSHPSA-N Gly-Phe-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O VDCRBJACQKOSMS-JSGCOSHPSA-N 0.000 description 2
- HQSKKSLNLSTONK-JTQLQIEISA-N Gly-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 HQSKKSLNLSTONK-JTQLQIEISA-N 0.000 description 2
- RIYIFUFFFBIOEU-KBPBESRZSA-N Gly-Tyr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 RIYIFUFFFBIOEU-KBPBESRZSA-N 0.000 description 2
- DNVDEMWIYLVIQU-RCOVLWMOSA-N Gly-Val-Asp Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O DNVDEMWIYLVIQU-RCOVLWMOSA-N 0.000 description 2
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- WECYRWOMWSCWNX-XUXIUFHCSA-N Ile-Arg-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O WECYRWOMWSCWNX-XUXIUFHCSA-N 0.000 description 2
- VZIFYHYNQDIPLI-HJWJTTGWSA-N Ile-Arg-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N VZIFYHYNQDIPLI-HJWJTTGWSA-N 0.000 description 2
- UMYZBHKAVTXWIW-GMOBBJLQSA-N Ile-Asp-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UMYZBHKAVTXWIW-GMOBBJLQSA-N 0.000 description 2
- JDAWAWXGAUZPNJ-ZPFDUUQYSA-N Ile-Glu-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N JDAWAWXGAUZPNJ-ZPFDUUQYSA-N 0.000 description 2
- JNLSTRPWUXOORL-MMWGEVLESA-N Ile-Ser-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N JNLSTRPWUXOORL-MMWGEVLESA-N 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 2
- KGCLIYGPQXUNLO-IUCAKERBSA-N Leu-Gly-Glu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O KGCLIYGPQXUNLO-IUCAKERBSA-N 0.000 description 2
- VGPCJSXPPOQPBK-YUMQZZPRSA-N Leu-Gly-Ser Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O VGPCJSXPPOQPBK-YUMQZZPRSA-N 0.000 description 2
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 2
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 2
- JDBQSGMJBMPNFT-AVGNSLFASA-N Leu-Pro-Val Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O JDBQSGMJBMPNFT-AVGNSLFASA-N 0.000 description 2
- HWMQRQIFVGEAPH-XIRDDKMYSA-N Leu-Ser-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 HWMQRQIFVGEAPH-XIRDDKMYSA-N 0.000 description 2
- AEDWWMMHUGYIFD-HJGDQZAQSA-N Leu-Thr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O AEDWWMMHUGYIFD-HJGDQZAQSA-N 0.000 description 2
- SUYRAPCRSCCPAK-VFAJRCTISA-N Leu-Trp-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SUYRAPCRSCCPAK-VFAJRCTISA-N 0.000 description 2
- VQHUBNVKFFLWRP-ULQDDVLXSA-N Leu-Tyr-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 VQHUBNVKFFLWRP-ULQDDVLXSA-N 0.000 description 2
- SJNZALDHDUYDBU-IHRRRGAJSA-N Lys-Arg-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(O)=O SJNZALDHDUYDBU-IHRRRGAJSA-N 0.000 description 2
- HYSVGEAWTGPMOA-IHRRRGAJSA-N Lys-Pro-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O HYSVGEAWTGPMOA-IHRRRGAJSA-N 0.000 description 2
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 2
- UAPZLLPGGOOCRO-IHRRRGAJSA-N Met-Asn-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N UAPZLLPGGOOCRO-IHRRRGAJSA-N 0.000 description 2
- OGAZPKJHHZPYFK-GARJFASQSA-N Met-Glu-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGAZPKJHHZPYFK-GARJFASQSA-N 0.000 description 2
- WPTDJKDGICUFCP-XUXIUFHCSA-N Met-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)N WPTDJKDGICUFCP-XUXIUFHCSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 2
- 108010079364 N-glycylalanine Proteins 0.000 description 2
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 2
- 108010065395 Neuropep-1 Proteins 0.000 description 2
- BKWJQWJPZMUWEG-LFSVMHDDSA-N Phe-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BKWJQWJPZMUWEG-LFSVMHDDSA-N 0.000 description 2
- DPUOLKQSMYLRDR-UBHSHLNASA-N Phe-Arg-Ala Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 DPUOLKQSMYLRDR-UBHSHLNASA-N 0.000 description 2
- KIEPQOIQHFKQLK-PCBIJLKTSA-N Phe-Asn-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KIEPQOIQHFKQLK-PCBIJLKTSA-N 0.000 description 2
- HOYQLNNGMHXZDW-KKUMJFAQSA-N Phe-Glu-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HOYQLNNGMHXZDW-KKUMJFAQSA-N 0.000 description 2
- MGECUMGTSHYHEJ-QEWYBTABSA-N Phe-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGECUMGTSHYHEJ-QEWYBTABSA-N 0.000 description 2
- JEBWZLWTRPZQRX-QWRGUYRKSA-N Phe-Gly-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O JEBWZLWTRPZQRX-QWRGUYRKSA-N 0.000 description 2
- UMIHVJQSXFWWMW-JBACZVJFSA-N Phe-Trp-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N UMIHVJQSXFWWMW-JBACZVJFSA-N 0.000 description 2
- ILMLVTGTUJPQFP-FXQIFTODSA-N Pro-Asp-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ILMLVTGTUJPQFP-FXQIFTODSA-N 0.000 description 2
- DEDANIDYQAPTFI-IHRRRGAJSA-N Pro-Asp-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O DEDANIDYQAPTFI-IHRRRGAJSA-N 0.000 description 2
- JFNPBBOGGNMSRX-CIUDSAMLSA-N Pro-Gln-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O JFNPBBOGGNMSRX-CIUDSAMLSA-N 0.000 description 2
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 2
- ULIWFCCJIOEHMU-BQBZGAKWSA-N Pro-Gly-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 ULIWFCCJIOEHMU-BQBZGAKWSA-N 0.000 description 2
- UIMCLYYSUCIUJM-UWVGGRQHSA-N Pro-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 UIMCLYYSUCIUJM-UWVGGRQHSA-N 0.000 description 2
- BFXZQMWKTYWGCF-PYJNHQTQSA-N Pro-His-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BFXZQMWKTYWGCF-PYJNHQTQSA-N 0.000 description 2
- IBGCFJDLCYTKPW-NAKRPEOUSA-N Pro-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 IBGCFJDLCYTKPW-NAKRPEOUSA-N 0.000 description 2
- CLJLVCYFABNTHP-DCAQKATOSA-N Pro-Leu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O CLJLVCYFABNTHP-DCAQKATOSA-N 0.000 description 2
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 2
- VPBQDHMASPJHGY-JYJNAYRXSA-N Pro-Trp-Ser Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CO)C(=O)O VPBQDHMASPJHGY-JYJNAYRXSA-N 0.000 description 2
- VBZXFFYOBDLLFE-HSHDSVGOSA-N Pro-Trp-Thr Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H]([C@H](O)C)C(O)=O)C(=O)[C@@H]1CCCN1 VBZXFFYOBDLLFE-HSHDSVGOSA-N 0.000 description 2
- DGDCSVGVWWAJRS-AVGNSLFASA-N Pro-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@@H]2CCCN2 DGDCSVGVWWAJRS-AVGNSLFASA-N 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 2
- SQBLRDDJTUJDMV-ACZMJKKPSA-N Ser-Glu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQBLRDDJTUJDMV-ACZMJKKPSA-N 0.000 description 2
- QBUWQRKEHJXTOP-DCAQKATOSA-N Ser-His-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QBUWQRKEHJXTOP-DCAQKATOSA-N 0.000 description 2
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 2
- PJIQEIFXZPCWOJ-FXQIFTODSA-N Ser-Pro-Asp Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O PJIQEIFXZPCWOJ-FXQIFTODSA-N 0.000 description 2
- KQNDIKOYWZTZIX-FXQIFTODSA-N Ser-Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KQNDIKOYWZTZIX-FXQIFTODSA-N 0.000 description 2
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 2
- FGBLCMLXHRPVOF-IHRRRGAJSA-N Ser-Tyr-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FGBLCMLXHRPVOF-IHRRRGAJSA-N 0.000 description 2
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 2
- PLQWGQUNUPMNOD-KKUMJFAQSA-N Ser-Tyr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PLQWGQUNUPMNOD-KKUMJFAQSA-N 0.000 description 2
- DFTCYYILCSQGIZ-GCJQMDKQSA-N Thr-Ala-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFTCYYILCSQGIZ-GCJQMDKQSA-N 0.000 description 2
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 description 2
- PXQUBKWZENPDGE-CIQUZCHMSA-N Thr-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)N PXQUBKWZENPDGE-CIQUZCHMSA-N 0.000 description 2
- GARULAKWZGFIKC-RWRJDSDZSA-N Thr-Gln-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GARULAKWZGFIKC-RWRJDSDZSA-N 0.000 description 2
- PAXANSWUSVPFNK-IUKAMOBKSA-N Thr-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N PAXANSWUSVPFNK-IUKAMOBKSA-N 0.000 description 2
- VTVVYQOXJCZVEB-WDCWCFNPSA-N Thr-Leu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VTVVYQOXJCZVEB-WDCWCFNPSA-N 0.000 description 2
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 2
- NDXSOKGYKCGYKT-VEVYYDQMSA-N Thr-Pro-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O NDXSOKGYKCGYKT-VEVYYDQMSA-N 0.000 description 2
- GFRIEEKFXOVPIR-RHYQMDGZSA-N Thr-Pro-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O GFRIEEKFXOVPIR-RHYQMDGZSA-N 0.000 description 2
- RVMNUBQWPVOUKH-HEIBUPTGSA-N Thr-Ser-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMNUBQWPVOUKH-HEIBUPTGSA-N 0.000 description 2
- YRJOLUDFVAUXLI-GSSVUCPTSA-N Thr-Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O YRJOLUDFVAUXLI-GSSVUCPTSA-N 0.000 description 2
- VGNLMPBYWWNQFS-ZEILLAHLSA-N Thr-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O VGNLMPBYWWNQFS-ZEILLAHLSA-N 0.000 description 2
- VGNKUXWYFFDWDH-BEMMVCDISA-N Thr-Trp-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@@H]3C(=O)O)N)O VGNKUXWYFFDWDH-BEMMVCDISA-N 0.000 description 2
- IJKNKFJZOJCKRR-GBALPHGKSA-N Thr-Trp-Ser Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 IJKNKFJZOJCKRR-GBALPHGKSA-N 0.000 description 2
- FYBFTPLPAXZBOY-KKHAAJSZSA-N Thr-Val-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O FYBFTPLPAXZBOY-KKHAAJSZSA-N 0.000 description 2
- BTAJAOWZCWOHBU-HSHDSVGOSA-N Thr-Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(O)=O)=CNC2=C1 BTAJAOWZCWOHBU-HSHDSVGOSA-N 0.000 description 2
- WFZYXGSAPWKTHR-XEGUGMAKSA-N Trp-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N WFZYXGSAPWKTHR-XEGUGMAKSA-N 0.000 description 2
- BIJDDZBDSJLWJY-PJODQICGSA-N Trp-Ala-Val Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O BIJDDZBDSJLWJY-PJODQICGSA-N 0.000 description 2
- LHHDBONOFZDWMW-AAEUAGOBSA-N Trp-Asp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N LHHDBONOFZDWMW-AAEUAGOBSA-N 0.000 description 2
- XLMDWQNAOKLKCP-XDTLVQLUSA-N Tyr-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N XLMDWQNAOKLKCP-XDTLVQLUSA-N 0.000 description 2
- CDHQEOXPWBDFPL-QWRGUYRKSA-N Tyr-Gly-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDHQEOXPWBDFPL-QWRGUYRKSA-N 0.000 description 2
- GIOBXJSONRQHKQ-RYUDHWBXSA-N Tyr-Gly-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O GIOBXJSONRQHKQ-RYUDHWBXSA-N 0.000 description 2
- CTDPLKMBVALCGN-JSGCOSHPSA-N Tyr-Gly-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O CTDPLKMBVALCGN-JSGCOSHPSA-N 0.000 description 2
- VBFVQTPETKJCQW-RPTUDFQQSA-N Tyr-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VBFVQTPETKJCQW-RPTUDFQQSA-N 0.000 description 2
- GQVZBMROTPEPIF-SRVKXCTJSA-N Tyr-Ser-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GQVZBMROTPEPIF-SRVKXCTJSA-N 0.000 description 2
- HRHYJNLMIJWGLF-BZSNNMDCSA-N Tyr-Ser-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 HRHYJNLMIJWGLF-BZSNNMDCSA-N 0.000 description 2
- NUQZCPSZHGIYTA-HKUYNNGSSA-N Tyr-Trp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N NUQZCPSZHGIYTA-HKUYNNGSSA-N 0.000 description 2
- JQOMHZMWQHXALX-FHWLQOOXSA-N Tyr-Tyr-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O JQOMHZMWQHXALX-FHWLQOOXSA-N 0.000 description 2
- REJBPZVUHYNMEN-LSJOCFKGSA-N Val-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N REJBPZVUHYNMEN-LSJOCFKGSA-N 0.000 description 2
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 2
- CVUDMNSZAIZFAE-TUAOUCFPSA-N Val-Arg-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N CVUDMNSZAIZFAE-TUAOUCFPSA-N 0.000 description 2
- CVUDMNSZAIZFAE-UHFFFAOYSA-N Val-Arg-Pro Natural products NC(N)=NCCCC(NC(=O)C(N)C(C)C)C(=O)N1CCCC1C(O)=O CVUDMNSZAIZFAE-UHFFFAOYSA-N 0.000 description 2
- DNOOLPROHJWCSQ-RCWTZXSCSA-N Val-Arg-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DNOOLPROHJWCSQ-RCWTZXSCSA-N 0.000 description 2
- QHFQQRKNGCXTHL-AUTRQRHGSA-N Val-Gln-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QHFQQRKNGCXTHL-AUTRQRHGSA-N 0.000 description 2
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 2
- MIKHIIQMRFYVOR-RCWTZXSCSA-N Val-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)N)O MIKHIIQMRFYVOR-RCWTZXSCSA-N 0.000 description 2
- AJNUKMZFHXUBMK-GUBZILKMSA-N Val-Ser-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AJNUKMZFHXUBMK-GUBZILKMSA-N 0.000 description 2
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 2
- YLBNZCJFSVJDRJ-KJEVXHAQSA-N Val-Thr-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O YLBNZCJFSVJDRJ-KJEVXHAQSA-N 0.000 description 2
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 2
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 108010068380 arginylarginine Proteins 0.000 description 2
- 108010060035 arginylproline Proteins 0.000 description 2
- 108010077245 asparaginyl-proline Proteins 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 108010038633 aspartylglutamate Proteins 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 2
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 108010045383 histidyl-glycyl-glutamic acid Proteins 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 108010060857 isoleucyl-valyl-tyrosine Proteins 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 108010005942 methionylglycine Proteins 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 108010030237 phenylalanyl-arginyl-valyl-phenylalanine Proteins 0.000 description 2
- 108010024607 phenylalanylalanine Proteins 0.000 description 2
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 108010070643 prolylglutamic acid Proteins 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 2
- 108010044292 tryptophyltyrosine Proteins 0.000 description 2
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- IXUSDMGLUJZNFO-BXUZGUMPSA-N (7R)-7-(4-carboxybutanamido)cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCCC(O)=O)[C@@H]12 IXUSDMGLUJZNFO-BXUZGUMPSA-N 0.000 description 1
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000004674 D-amino-acid oxidase Human genes 0.000 description 1
- 108010003989 D-amino-acid oxidase Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- WNZOCXUOGVYYBJ-CDMKHQONSA-N Gly-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CN)O WNZOCXUOGVYYBJ-CDMKHQONSA-N 0.000 description 1
- ZZWUYQXMIFTIIY-WEDXCCLWSA-N Gly-Thr-Leu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O ZZWUYQXMIFTIIY-WEDXCCLWSA-N 0.000 description 1
- GWNIGUKSRJBIHX-STQMWFEESA-N Gly-Tyr-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)CN)O GWNIGUKSRJBIHX-STQMWFEESA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- -1 glutaryl Chemical group 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention belongs to the technical field of biological engineering, and particularly relates to a cephalosporin C acylase mutant as well as a preparation method and application thereof. The cephalosporin C acylase mutant has the amino acid sequence shown in SEQ ID NO: 2, or a pharmaceutically acceptable salt thereof. The amino acid sequence of SEQ ID NO: 2 by comparing the amino acid sequence shown in SEQ ID NO:1, and performing substitution mutation on the 245-247 amino acid of the amino acid sequence shown in the specification; wherein, the 245 th tyrosine is mutated into phenylalanine, the 246 th arginine is mutated into methionine, and the 247 th leucine is mutated into serine. Compared with the wild GL-7-ACA acylase SED ID NO:1 enzyme activity is improved by more than 210 times, and the method can be applied to one-step enzyme method production of 7-aminocephalosporanic acid (7-ACA).
Description
Technical Field
The invention belongs to the technical field of biological engineering, and particularly relates to a cephalosporin C acylase mutant as well as a preparation method and application thereof.
Background
7-aminocephalosporanic acid (7-ACA) is a main precursor for synthesis of beta-lactam antibiotics, and is mainly synthesized industrially by a chemical method and an enzymatic method. However, the chemical synthesis method has complex process, serious pollution and high energy consumption, and has been replaced by a biological enzyme method in recent years, the biological enzyme method has simple process and mild reaction condition, and the prepared product has stable quality. The chemical method is mature in process, and compared with the chemical method, the biological enzyme method has a large space for rising. With the gradual increase of the national requirements on green environmental protection, the biological enzyme method has a better future prospect.
At present, biological enzyme methods are mainly divided into a one-step enzyme method and a two-step enzyme method. The two-step enzyme method relates to step-by-step catalysis of D-amino acid oxidase and glutaryl transferase, and has been reported to be applied to industrial production. The one-step enzymatic approach involves the direct catalytic production of 7-ACA using cephalosporin C acylase on the substrate CPC. Compared with a two-step enzyme method, the one-step enzyme method has the advantages of simpler process, low equipment requirement, low production cost and the like. However, compared with GL-7-ACA acylase prepared by a two-step enzyme method, the cephalosporin C acylase prepared by the one-step enzyme method has low catalytic efficiency on CPC, and only catalyzes GL-7-ACA by 2% -4%.
Chinese patent CN 108220276A discloses a cephalosporin C acylase mutant and application thereof in 7-aminocephalosporanic acid production, the cephalosporin C acylase mutant can catalyze cephalosporin C to generate 7-aminocephalosporanic acid, the cephalosporin C acylase mutant has higher catalytic activity compared with wild cephalosporin C acylase, and the enzyme activity is improved by about 8.6 times. Obtaining a gene sequence, recombining and expressing protein, detecting enzyme activity and preparing 7-aminocephalosporanic acid by using the primer A.
Chinese patent CN 110129305A discloses a cephalosporin C acylase mutant for preparing 7-ACA, wherein the amino acid sequence of the cephalosporin C acylase is SEQ ID NO. 4, compared with wild type GL-7-ACA acylase SEQ ID NO. 1 from Pseudomonas GK16(Pseudomonas sp.GK16), the enzyme activity is improved by 52 times, and the cephalosporin C acylase mutant can be used for producing 7-aminocephalosporanic acid (7-ACA) by a one-step enzyme method.
Although the enzyme activity of the cephalosporin C acylase mutants provided by the two patents is respectively improved by 8.6 times and 52 times compared with that of the wild cephalosporin C acylase, the enzyme activity is still lower, and the industrial production efficiency is low.
Disclosure of Invention
The invention aims to provide a cephalosporin C acylase mutant which has high enzyme activity and high industrial production efficiency; the invention also provides a preparation method and application of the cephalosporin C acylase mutant.
The cephalosporin C acylase mutant provided by the invention has the amino acid sequence shown in SEQ ID NO: 2, or a pharmaceutically acceptable salt thereof.
The amino acid sequence of SEQ ID NO: 2 by comparing the amino acid sequence shown in SEQ ID NO:1, and performing substitution mutation on the 245-247 amino acid of the amino acid sequence shown in the specification; wherein, the 245 th tyrosine is mutated into phenylalanine, the 246 th arginine is mutated into methionine, and the 247 th leucine is mutated into serine.
SEQ ID NO: 2 is the amino acid sequence shown in SEQ ID NO: 3, and (b) 3.
SEQ ID NO: 3 by comparing the nucleotide sequence shown in SEQ ID NO:4, and the base numbers 215, 232, 239, 250, 252, 268 and 327 of the DNA sequence shown in the specification are subjected to substitution mutation; wherein, the 215 th adenine mutation is thymine, the 232 th adenine mutation is thymine, the 239 th guanine mutation is cytosine, the 250 th cytosine mutation is guanine, the 252 th thymine mutation is adenine, the 268 th adenine mutation is thymine, and the 327 th guanine mutation is cytosine.
The preparation method of the cephalosporin C acylase mutant comprises the following steps:
(1) converting SEQ ID NO:4 to obtain the DNA sequence shown in SEQ ID NO: 2 in sequence (b);
(2) cloning the coding gene into a plasmid vector to obtain a recombinant plasmid;
(3) introducing the recombinant plasmid into an escherichia coli competent cell to obtain a recombinant bacterium;
(4) and performing induction fermentation on the recombinant bacteria to obtain the cephalosporin C acylase mutant.
The double-point mutation step in the step (1) is carried out by using SEQ ID NO:4 as template, adding primer to perform PCR amplification;
the primer sequences are as follows:
the upstream primer F1: GGGAATTCCATATGCT F2: GAGAGTTCTGCACCG the flow of the air in the air conditioner,
the downstream primer R1: CCCGGAATTCTCATGG R2: CTTGAAGTTGAAGTTGAAGG the flow of the air in the air conditioner,
wherein, F1 and R2 contain 20bp homology arms, and F2 and R1 contain 20bp homology arms.
The PCR amplification system is as follows:
the PCR reaction condition is pre-denaturation at 98 ℃ for 3 min; denaturation at 98 ℃ for 10s, annealing at 45 ℃ for 5s, extension at 72 ℃ for 3min, and 30 cycles; extension at 72 ℃ for 10 min.
In the step (2), the plasmid carrier is PET-28a+。
And (5) adding IPTG to perform induction fermentation in the step (4).
The application of the cephalosporin C acylase mutant is that the cephalosporin C acylase mutant is used for preparing 7-aminocephalosporanic acid.
The invention has the following beneficial effects:
in order to overcome the defect of low catalytic efficiency of CPC catalyzed by a one-step enzyme method and obtain CPC acylase with higher enzyme activity efficiency, the invention carries out gene mutation and screening on wild type GL-7-ACA acylase (SED ID NO: 1) from pseudomonas GK16 by using genetic engineering technologies such as point mutation and the like to prepare the cephalosporin C acylase mutant with higher enzyme activity efficiency.
Compared with the wild GL-7-ACA acylase SED ID NO:1 enzyme activity is improved by more than 210 times, and the method can be applied to one-step enzyme method production of 7-aminocephalosporanic acid (7-ACA).
Drawings
FIG. 1 is an electrophoretic verification chart of true positive transformants obtained in example 1.
Detailed Description
The present invention is further described below with reference to examples.
Example 1
(1) Using CPC acylase wild type gene SEQ ID NO:4, cloning target genes by taking the primer sequences as follows: the upstream primer F1: GGGAATTCCATATGCT F2: GAGAGTTCTGCACCG downstream primer R1: CCCGGAATTCTCATGG R2: CTTGAAGTTGAAGTTGAAGG, wherein F1 and R2 contain 20bp homology arms, and F2 and R1 contain 20bp homology arms, thereby carrying out double-point mutation.
(2) The PCR amplification system is as follows:
the PCR reaction condition is pre-denaturation at 98 ℃ for 3 min; denaturation at 98 ℃ for 10s, annealing at 45 ℃ for 5s, extension at 72 ℃ for 3min, and 30 cycles; extension at 72 ℃ for 10 min.
(3) Subsequently, a purification kit is adopted to purify and purify the PCR product, the obtained target gene is subjected to double enzyme digestion by BamHI and HinDIII endonucleases, and the plasmid vector PET-28a is subjected to double enzyme digestion+Carrying out the same double enzyme digestion to obtain the recombinant plasmid PET-28a+-CPCA. Escherichia coli TG1 is made into Escherichia coli competent cell by calcium chloride method, and the obtained recombinant plasmid is introducedThe obtained transformant was named TG1/PET-28a after being introduced into E.coli competent cells+-CPCA. Mixing TG1/PET-28a+CPCA was spread evenly on LB plates (containing ampicillin resistance), incubated overnight at 37 ℃ and plasmids were extracted from single colonies growing on the plates.
The primer sequence for designing the recombinant plasmid is as follows: f: CGAAATCTTTGTTGGTGGG R: ATGAAGGATACATAAACGGCTAC are provided.
The PCR amplification system is as follows:
the PCR reaction condition is pre-denaturation at 98 ℃ for 3 min; denaturation at 98 ℃ for 10s, annealing at 45 ℃ for 5s, extension at 72 ℃ for 3min, and 30 cycles; extension at 72 ℃ for 10 min.
And (3) carrying out nucleic acid electrophoresis verification on the amplification product, wherein the electrophoresis result is shown in figure 1, and the single colony picked is confirmed to be a true positive transformant.
(4) Selecting the colony of the verified true positive transformant to an LB liquid culture medium containing ampicillin, adding 0.1mM IPTG at 37 ℃ and 200rpm to promote the expression of the target protein, and shaking the bacteria overnight until the OD value is 0.6-0.8 to obtain a bacterial liquid; centrifuging the bacterial liquid at 4000rpm for 10min, discarding the supernatant, retaining the precipitate, freezing at-20 ℃ for 1h, thawing at normal temperature, adding 200ul of 0.9% physiological saline, cracking the bacteria by using an ultrasonic cell crusher, incubating at 37 ℃ for 1h, centrifuging at 4000rpm for 10min to obtain a cephalosporin C acylase mutant, and retaining 20ul of the supernatant for CPC activity determination.
(5) And (4) resuspending the bacterial liquid obtained in the step (4) by using 50ml of buffer solution, carrying out ultrasonic lysis, centrifuging the crushed thallus at 12000rpm at 4 ℃ for 20min, and collecting supernatant. The supernatant was passed through a nickel column at a rate of 1ml/min, the nickel column was washed with 30mM imidazole, the hetero-protein was washed with 300mM imidazole, the target protein was collected until the reaction solution did not turn blue any more, and the peak eluent was collected. Desalting the obtained eluate with 10KD hyperconcentration column, and removing acylase to obtain purified enzyme. The Protein concentration of the purified enzyme was determined using Protein Assay Kit to obtain the specific activity of the purified enzyme. The results of enzyme activity measurement of wild-type CPC acylase (wtCPC) and various CPC acylase mutants are shown in table 1.
TABLE 1 measurement results of enzyme activities of wild-type CPC acylase and various CPC acylase mutants
As is clear from Table 1, by substituting an amino acid in the wild-type CPC acylase, a mutant strain ED4 (CPC acylase mutant prepared in example 1) having a relative specific activity increased 210.1-fold was obtained.
The invention successfully constructs the CPC acylase mutant, successfully improves the specific activity of wild acylase by more than 210 times, has faster reaction efficiency when being used for producing 7-ACA, and has wide industrialization prospect.
(6) The substrate reaction solution was 0.1M potassium phosphate salt buffer (ph8.0) containing 2 wt.% CPC sodium salt,
terminating the reaction solution: 0.05M NaOH, 20 v/v% glacial acetic acid,
color developing agent: containing 0.5 wt% of PDAB in methanol,
definition of enzyme activity: the amount of enzyme required to catalyze CPC to produce 1uM7-ACA per minute was defined as one unit (U).
Adding 20ul of each of the wild-type CPC acylase and the CPC acylase mutants in the step (5) into a substrate reaction solution, culturing overnight at 37 ℃, adding 200ul of a termination reaction solution, centrifuging at 5000rpm for 10min, adding 40ul of a color developing agent, reacting for 10min, and detecting the yield of 7-ACA under the absorbance of 415nm, wherein the results are shown in Table 2.
TABLE 2 determination of 7-ACA yields of wild-type CPC acylase and various CPC acylase mutants
| Strain numbering | wtCPC | ED1 | ED2 | ED3 | ED4 |
| 7-ACA yield (ug/min) | 0.15 | 0.69 | 17.8 | 23.1 | 32 |
(7) Effect of medium pH on cephalosporin C acylase secretion expression
After the bacterial liquids obtained in the step (4) are respectively cultured in LB culture media with pH values of 7.5, 8.0, 8.5, 9.0 and 9.5 for 24 hours, the activity of cephalosporin C acylase of respective intact cells is determined, and the results are shown in Table 3.
TABLE 3 determination of cephalosporin C acylase Activity
As is clear from Table 3, the enzyme activity was the greatest and the expression level was the highest when cultured in a medium having a pH of 8.0.
Sequence listing
<110> Shandong Kingkory chemical Co., Ltd
<120> cephalosporin C acylase mutant and preparation method and application thereof
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 688
<212> PRT
<213> Pseudomonas sp .GK16
<400> 1
Met Glu Pro Thr Ser Thr Pro Gln Ala Pro Ile Ala Ala Tyr Lys Pro
1 5 10 15
Arg Ser Asn Glu Ile Leu Trp Asp Gly Tyr Gly Val Pro His Ile Tyr
20 25 30
Gly Val Asp Ala Pro Ser Ala Phe Tyr Gly Tyr Gly Trp Ala Gln Ala
35 40 45
Arg Ser His Gly Asp Asn Ile Arg Leu Tyr Gly Glu Ala Arg Gly Lys
50 55 60
Gly Ala Glu Tyr Trp Gly Pro Asp Tyr Glu Gln Thr Thr Val Trp Leu
65 70 75 80
Leu Thr Asn Gly Val Pro Glu Arg Ala Gln Gln Trp Tyr Ala Gln Gln
85 90 95
Ser Pro Asp Phe Arg Ala Asn Leu Asp Ala Phe Ala Ala Gly Ile Asn
100 105 110
Ala Tyr Ala Gln Gln Asn Pro Asp Asp Ile Ser Pro Glu Val Arg Gln
115 120 125
Val Leu Pro Val Ser Gly Ala Asp Val Val Ala His Ala His Arg Leu
130 135 140
Met Asn Phe Leu Tyr Val Ala Ser Pro Gly Arg Thr Leu Gly Glu Gly
145 150 155 160
Asp Pro Pro Asp Leu Ala Asp Gln Gly Ser Asn Ser Trp Ala Val Ala
165 170 175
Pro Gly Lys Thr Ala Asn Gly Asn Ala Leu Leu Leu Gln Asn Pro His
180 185 190
Leu Ser Trp Thr Thr Asp Tyr Phe Thr Tyr Tyr Glu Ala His Leu Val
195 200 205
Thr Pro Asp Phe Glu Ile Tyr Gly Ala Thr Gln Ile Gly Leu Pro Val
210 215 220
Ile Arg Phe Ala Phe Asn Gln Arg Met Gly Ile Thr Asn Thr Val Asn
225 230 235 240
Gly Met Val Gly Tyr Arg Leu Thr Leu Gln Asp Gly Gly Tyr Leu Tyr
245 250 255
Asp Gly Gln Val Arg Pro Phe Glu Arg Arg Gln Ala Ser Tyr Arg Leu
260 265 270
Arg Gln Ala Asp Gly Thr Thr Val Asp Lys Pro Leu Glu Ile Arg Ser
275 280 285
Ser Val His Gly Pro Val Phe Glu Arg Ala Asp Gly Thr Ala Val Ala
290 295 300
Val Arg Val Ala Gly Leu Asp Arg Pro Gly Met Leu Glu Gln Tyr Phe
305 310 315 320
Asp Met Ile Thr Ala Asp Ser Ser Asp Asp Tyr Glu Ala Ala Leu Ala
325 330 335
Arg Met Gln Val Pro Thr Phe Asn Ile Val Tyr Ala Asp Arg Glu Gly
340 345 350
Thr Ile Asn Tyr Ser Phe Asn Gly Val Ala Pro Lys Arg Ala Glu Gly
355 360 365
Asp Ile Ala Phe Trp Gln Gly Leu Val Pro Gly Asp Ser Ser Arg Tyr
370 375 380
Leu Trp Thr Glu Thr His Pro Leu Asp Asp Leu Pro Glu Val Thr Asn
385 390 395 400
Pro Pro Gly Gly Phe Val Gln Asn Ser Asn Asp Pro Pro Trp Thr Pro
405 410 415
Thr Trp Pro Val Thr Tyr Thr Pro Lys Asp Phe Pro Ser Tyr Leu Ala
420 425 430
Pro Gln Thr Pro His Ser Leu Arg Ala Gln Gln Ser Val Arg Leu Met
435 440 445
Ser Glu Asn Asp Asp Leu Thr Leu Glu Arg Phe Met Ala Leu Gln Leu
450 455 460
Ser His Arg Ala Val Met Ala Asp Arg Thr Leu Pro Asp Leu Ile Pro
465 470 475 480
Ala Ala Leu Ile Asp Pro Asp Pro Glu Val Gln Ala Ala Ala Arg Leu
485 490 495
Leu Ala Ala Trp Asp Arg Glu Phe Thr Ser Asp Ser Arg Ala Ala Leu
500 505 510
Leu Phe Glu Glu Trp Ala Arg Leu Phe Ala Gly Gln Asn Phe Ala Gly
515 520 525
Gln Ala Gly Phe Ala Thr Pro Trp Ser Ser Leu Asp Lys Pro Val Ser
530 535 540
Thr Pro Tyr Gly Val Arg Asp Pro Lys Ala Ala Val Asn Gln Leu Arg
545 550 555 560
Thr Ala Ile Ala Asn Thr Lys Arg Lys Tyr Gly Ala Ile Asp Arg Pro
565 570 575
Phe Gly Asp Ala Ser Arg Met Ile Leu Asn Asp Val Asn Val Pro Gly
580 585 590
Ala Ala Gly Tyr Gly Asn Leu Gly Ser Phe Arg Val Phe Thr Trp Ser
595 600 605
Asp Pro Asp Glu Asn Gly Val Arg Thr Pro Val His Gly Glu Thr Trp
610 615 620
Val Ala Met Ile Glu Phe Ser Thr Pro Val Arg Ala Tyr Gly Leu Met
625 630 635 640
Ser Tyr Gly Asn Ser Arg Gln Pro Gly Thr Thr His Tyr Ser Asp Gln
645 650 655
Ile Glu Arg Val Ser Arg Ala Asp Phe Arg Glu Leu Leu Leu Arg Arg
660 665 670
Glu Gln Val Glu Ala Ala Val Gln Glu Arg Pro Phe Asn Phe Lys Pro
675 680 685
<210> 2
<211> 688
<212> PRT
<213> Artificial
<400> 2
Met Glu Pro Thr Ser Thr Pro Gln Ala Pro Ile Ala Ala Tyr Lys Pro
1 5 10 15
Arg Ser Asn Glu Ile Leu Trp Asp Gly Tyr Gly Val Pro His Ile Tyr
20 25 30
Gly Val Asp Ala Pro Ser Ala Phe Tyr Gly Tyr Gly Trp Ala Gln Ala
35 40 45
Arg Ser His Gly Asp Asn Ile Arg Leu Tyr Gly Glu Ala Arg Gly Lys
50 55 60
Gly Ala Glu Tyr Trp Gly Pro Asp Tyr Glu Gln Thr Thr Val Trp Leu
65 70 75 80
Leu Thr Asn Gly Val Pro Glu Arg Ala Gln Gln Trp Tyr Ala Gln Gln
85 90 95
Ser Pro Asp Phe Arg Ala Asn Leu Asp Ala Phe Ala Ala Gly Ile Asn
100 105 110
Ala Tyr Ala Gln Gln Asn Pro Asp Asp Ile Ser Pro Glu Val Arg Gln
115 120 125
Val Leu Pro Val Ser Gly Ala Asp Val Val Ala His Ala His Arg Leu
130 135 140
Met Asn Phe Leu Tyr Val Ala Ser Pro Gly Arg Thr Leu Gly Glu Gly
145 150 155 160
Asp Pro Pro Asp Leu Ala Asp Gln Gly Ser Asn Ser Trp Ala Val Ala
165 170 175
Pro Gly Lys Thr Ala Asn Gly Asn Ala Leu Leu Leu Gln Asn Pro His
180 185 190
Leu Ser Trp Thr Thr Asp Tyr Phe Thr Tyr Tyr Glu Ala His Leu Val
195 200 205
Thr Pro Asp Phe Glu Ile Tyr Gly Ala Thr Gln Ile Gly Leu Pro Val
210 215 220
Ile Arg Phe Ala Phe Asn Gln Arg Met Gly Ile Thr Asn Thr Val Asn
225 230 235 240
Gly Met Val Gly Phe Thr Gly Thr Leu Gln Asp Gly Gly Tyr Leu Tyr
245 250 255
Asp Gly Gln Val Arg Pro Phe Glu Arg Arg Gln Ala Ser Tyr Arg Leu
260 265 270
Arg Gln Ala Asp Gly Thr Thr Val Asp Lys Pro Leu Glu Ile Arg Ser
275 280 285
Ser Val His Gly Pro Val Phe Glu Arg Ala Asp Gly Thr Ala Val Ala
290 295 300
Val Arg Val Ala Gly Leu Asp Arg Pro Gly Met Leu Glu Gln Tyr Phe
305 310 315 320
Asp Met Ile Thr Ala Asp Ser Ser Asp Asp Tyr Glu Ala Ala Leu Ala
325 330 335
Arg Met Gln Val Pro Thr Phe Asn Ile Val Tyr Ala Asp Arg Glu Gly
340 345 350
Thr Ile Asn Tyr Ser Phe Asn Gly Val Ala Pro Lys Arg Ala Glu Gly
355 360 365
Asp Ile Ala Phe Trp Gln Gly Leu Val Pro Gly Asp Ser Ser Arg Tyr
370 375 380
Leu Trp Thr Glu Thr His Pro Leu Asp Asp Leu Pro Glu Val Thr Asn
385 390 395 400
Pro Pro Gly Gly Phe Val Gln Asn Ser Asn Asp Pro Pro Trp Thr Pro
405 410 415
Thr Trp Pro Val Thr Tyr Thr Pro Lys Asp Phe Pro Ser Tyr Leu Ala
420 425 430
Pro Gln Thr Pro His Ser Leu Arg Ala Gln Gln Ser Val Arg Leu Met
435 440 445
Ser Glu Asn Asp Asp Leu Thr Leu Glu Arg Phe Met Ala Leu Gln Leu
450 455 460
Ser His Arg Ala Val Met Ala Asp Arg Thr Leu Pro Asp Leu Ile Pro
465 470 475 480
Ala Ala Leu Ile Asp Pro Asp Pro Glu Val Gln Ala Ala Ala Arg Leu
485 490 495
Leu Ala Ala Trp Asp Arg Glu Phe Thr Ser Asp Ser Arg Ala Ala Leu
500 505 510
Leu Phe Glu Glu Trp Ala Arg Leu Phe Ala Gly Gln Asn Phe Ala Gly
515 520 525
Gln Ala Gly Phe Ala Thr Pro Trp Ser Ser Leu Asp Lys Pro Val Ser
530 535 540
Thr Pro Tyr Gly Val Arg Asp Pro Lys Ala Ala Val Asn Gln Leu Arg
545 550 555 560
Thr Ala Ile Ala Asn Thr Lys Arg Lys Tyr Gly Ala Ile Asp Arg Pro
565 570 575
Phe Gly Asp Ala Ser Arg Met Ile Leu Asn Asp Val Asn Val Pro Gly
580 585 590
Ala Ala Gly Tyr Gly Asn Leu Gly Ser Phe Arg Val Phe Thr Trp Ser
595 600 605
Asp Pro Asp Glu Asn Gly Val Arg Thr Pro Val His Gly Glu Thr Trp
610 615 620
Val Ala Met Ile Glu Phe Ser Thr Pro Val Arg Ala Tyr Gly Leu Met
625 630 635 640
Ser Tyr Gly Asn Ser Arg Gln Pro Gly Thr Thr His Tyr Ser Asp Gln
645 650 655
Ile Glu Arg Val Ser Arg Ala Asp Phe Arg Glu Leu Leu Leu Arg Arg
660 665 670
Glu Gln Val Glu Ala Ala Val Gln Glu Arg Pro Phe Asn Phe Lys Pro
675 680 685
<210> 3
<211> 2364
<212> DNA
<213> Artificial
<400> 3
atggaaccga cctctacccc gcaggctccg atcgctgctt acaaaccgcg ttctaacgaa 60
atcctgtggg acggttacgg tgttccgcac tctacggtgt tgacgctcca tcggcgttct 120
acggttacgg ctgggctcag gctcgttctc acggtgacaa catcctgcgt ctgtacggtg 180
aagctgtggt aaaggtgctg aatactgggg tccggactac gaacagacca ccgtttggct 240
gctgaccaac ggtgttccgg aacgtgctca gcagtggtac gctcagcagt ctccggactt 300
cctgtctaac ctggacgctt tcgctgctgg tatcaacgca gaacccggac gacatctctc 360
cggaagttcg tcaagttctg ccggtaagcg gtgctgacgt tgttgctcac gctcacgctc 420
accgtctgat gaacttcctg tacgttgctt ctccgggtcg taccctgggt gaaggtgacc 480
cgccggacct ggctgaccag ggttctaact cttgggctgt tgctccgggt aaaaccgcta 540
acggtaacgc tctgctgctg ctgcagaacc cgcacctgtc ttggaccacc gactactcta 600
cctactacga agctcacctg gttaccccgg acttcgaagt ttacggtgct acccagatcg 660
gtctgccggt tatccgtgtt gctttcaacc agcgtatggg tatcaccaac accttcaacg 720
gtatggttgg gtgctaccaa ctaccgcttg accctgcagg acggtggtta cctgtacgac 780
ggtcaggttc gtccgttcga acgtcgtcag gcttcttacc gtctgcgtca ggctgacggt 840
accaccgttg acaaaccgct ggaaatccgt tcttctgttc acggtccggt tttcgaacgt 900
gctgacggta cggtaccgct gttgctgttg ctgttcgtgt tgctggtctg gaccgtccgg 960
gtatgctgga acagaccttc gacatgatca ccgctgactc tttcgacgac tacgaagctg 1020
ctctggctcg tatgcaggtt ccgaccttca acatcgttta cgctgaccgt gaaggtacca 1080
tcaactactc tttcaacggt gttgctccga aacgtgctga aggtgacatc gctttctggc 1140
agggtctggt tccgggtgac tcttctcgtt acctgtggac cgaaacccac ccgctggacg 1200
acctgccgcg tgttaccaac ccgccgttcg ccgagaccga cctttccttc gattgcctga 1260
cgcggatgcc gggcgcatcg accgtggcgc agctttacga cgcgacgcgc ggctggggcc 1320
tgatcgacca taatcgacca taatctcgtc gccggggatg tcgcgggctc gatcggccat 1380
ctggtccgcg cccgcgtccc gtcccgcccg cgcgagaacg gctggctgcc ggtgccgggc 1440
tggtccggcg tggtccggcg agcatgaatg gcgcggctgg attccgcacg aggcgatgcc 1500
gcgcgtcatc gatccgccgg gcggcctcat cgtcacggcg aacaaccgcg tcgtggccga 1560
tgatcatccc gattatctct gtaccgattg ccatccgccc taccgcgccg aacggatcat 1620
ggagcgcctg gtcgccagtc cggctttcgc cgtcgacgat gcggccgcga tccacgccga 1680
tacgctgtcc cccatgtcgg cttgctgcgc gcgaggctcg aagcgctcgg aatccagggc 1740
agtctccctg ccgaagagtt gaggcagacc ctcatcgcct gggacggccg catggatgct 1800
ggctcgcagg cggcttccgc ttataatgcg ttccgcaggg cgctgacgcg gctggtaacg 1860
gcccgcagcg ggctggagca agcgatagcg catcccttcc tgcgcaacga cgatgccggg 1920
atgctgaaag gctggagctg ggacgaggcc ttgtcggagg ccctgtccgt cgcgacgcag 1980
aacctgaccg ggcgcggctg gggcgaggag catcggccgc gtttcacgca cccgctctcc 2040
gcgcagttcc cggcctgggc cgcgctgctg aacccggttt cgcgcccgat cggcggcgat 2100
ggcgacaccg tgctggcgaa cgggctcgtc ccatcggccg gacctgaggc gacctatggc 2160
gccctgtcgc gctacgtctt cgatgtcggc aattgggaca atagccgctg ggtcgtcttc 2220
cacggcgcct cggggcactc ggccagcccc cactatgccg accagaatgc gccatggagc 2280
gactgcgcga tggtgccgat gctctatagc tgggacagga tcgccgcgga ggccgtgacc 2340
tcgcaggaac tcgtcccggc ctga 2364
<210> 4
<211> 2364
<212> DNA
<213> Pseudomonas sp .GK16
<400> 4
atggaaccga cctctacccc gcaggctccg atcgctgctt acaaaccgcg ttctaacgaa 60
atcctgtggg acggttacgg tgttccgcac tctacggtgt tgacgctcca tcggcgttct 120
acggttacgg ctgggctcag gctcgttctc acggtgacaa catcctgcgt ctgtacggtg 180
aagctgtggt aaaggtgctg aatactgggg tccggactac gaacagacca ccgtttggct 240
gctgaccaac ggtgttccgg aacgtgctca gcagtggtac gctcagcagt ctccggactt 300
cctgtctaac ctggacgctt tcgctgctgg tatcaacgca gaacccggac gacatctctc 360
cggaagttcg tcaagttctg ccggtaagcg gtgctgacgt tgttgctcac gctcacgctc 420
accgtctgat gaacttcctg tacgttgctt ctccgggtcg taccctgggt gaaggtgacc 480
cgccggacct ggctgaccag ggttctaact cttgggctgt tgctccgggt aaaaccgcta 540
acggtaacgc tctgctgctg ctgcagaacc cgcacctgtc ttggaccacc gactactcta 600
cctactacga agctcacctg gttaccccgg acttcgaagt ttacggtgct acccagatcg 660
gtctgccggt tatccgtgtt gctttcaacc agcgtatggg tatcaccaac accttcaacg 720
gtatggttgg gtgctaccaa ctaccgctac tgggacgtgg acggtggtta cctgtacgac 780
ggtcaggttc gtccgttcga acgtcgtcag gcttcttacc gtctgcgtca ggctgacggt 840
accaccgttg acaaaccgct ggaaatccgt tcttctgttc acggtccggt tttcgaacgt 900
gctgacgcat gccatgcgct gttgctgttg ctgttcgtgt tgctggtctg gaccgtccgg 960
gtatgctgga acagaccttc gacatgatca ccgctgactc tttcgacgac tacgaagctg 1020
ctctggctcg tatgcaggtt ccgaccttca acatcgttta cgctgaccgt gaaggtacca 1080
tcaactactc tttcaacgca caagctccga aacgtgctga aggtgacatc gctttctggc 1140
agggtctggt tccgggtgac tcttctcgtt acctgtggac cgaaacccac ccgctggacg 1200
acctgccgcg tgttaccaac ccgccgttcg ccgagaccga cctttccttc gattgcctga 1260
cgcggatgcc gggcgcatcg accgtggcgc agctttacga cgcgacgcgc ggctggggcc 1320
tgatcgacca taatcgacca taatctcgtc gccggggatg tcgcgggctc gatcggccat 1380
ctggtccgcg cccgcgtccc gtcccgcccg cgcgagaacg gctggctgcc ggtgccgggc 1440
tggtccggcg tggtccggcg agcatgaatg gcgcggctgg attccgcacg aggcgatgcc 1500
gcgcgtcatc gatccgccgg gcggcctcat cgtcacggcg aacaaccgcg tcgtggccga 1560
tgatcatccc gattatctct gtaccgattg ccatccgccc taccgcgccg aacggatcat 1620
ggagcgcctg gtcgccagtc cggctttcgc cgtcgacgat gcggccgcga tccacgccga 1680
tacgctgtcc cccatgtcgg cttgctgcgc gcgaggctcg aagcgctcgg aatccagggc 1740
agtctccctg ccgaagagtt gaggcagacc ctcatcgcct gggacggccg catggatgct 1800
ggctcgcagg cggcttccgc ttataatgcg ttccgcaggg cgctgacgcg gctggtaacg 1860
gcccgcagcg ggctggagca agcgatagcg catcccttcc tgcgcaacga cgatgccggg 1920
atgctgaaag gctggagctg ggacgaggcc ttgtcggagg ccctgtccgt cgcgacgcag 1980
aacctgaccg ggcgcggctg gggcgaggag catcggccgc gtttcacgca cccgctctcc 2040
gcgcagttcc cggcctgggc cgcgctgctg aacccggttt cgcgcccgat cggcggcgat 2100
ggcgacaccg tgctggcgaa cgggctcgtc ccatcggccg gacctgaggc gacctatggc 2160
gccctgtcgc gctacgtctt cgatgtcggc aattgggaca atagccgctg ggtcgtcttc 2220
cacggcgcct cggggcactc ggccagcccc cactatgccg accagaatgc gccatggagc 2280
gactgcgcga tggtgccgat gctctatagc tgggacagga tcgccgcgga ggccgtgacc 2340
tcgcaggaac tcgtcccggc ctga 2364
Claims (5)
1. A cephalosporin C acylase mutant characterized in that its amino acid sequence is SEQ ID NO: 2.
2. a method for preparing the cephalosporin C acylase mutant of claim 1, characterized in that it comprises the steps of:
(1) converting SEQ ID NO:4 to obtain the DNA sequence shown in SEQ ID NO: 2 in sequence (b);
(2) cloning the coding gene into a plasmid vector to obtain a recombinant plasmid;
(3) introducing the recombinant plasmid into an escherichia coli competent cell to obtain a recombinant bacterium;
(4) and performing induction fermentation on the recombinant bacteria to obtain the cephalosporin C acylase mutant.
3. The method for preparing cephalosporin C acylase mutant according to claim 2, characterized in that the plasmid carrier in step (2) is PET-28a+。
4. The method for preparing cephalosporin C acylase mutant according to claim 2, characterized in that the induction fermentation in step (4) is an induction fermentation with IPTG.
5. Use of a cephalosporin C acylase mutant according to claim 1 for the preparation of 7-aminocephalosporanic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011591118.8A CN112662655B (en) | 2020-12-29 | 2020-12-29 | Cephalosporin C acylase mutant and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011591118.8A CN112662655B (en) | 2020-12-29 | 2020-12-29 | Cephalosporin C acylase mutant and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112662655A CN112662655A (en) | 2021-04-16 |
| CN112662655B true CN112662655B (en) | 2022-05-03 |
Family
ID=75411808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011591118.8A Active CN112662655B (en) | 2020-12-29 | 2020-12-29 | Cephalosporin C acylase mutant and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112662655B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113637656A (en) * | 2021-08-05 | 2021-11-12 | 云南师范大学 | GDSL family deacetylation esterase mutant Est8-G45R and application thereof |
| CN113637653B (en) * | 2021-08-05 | 2023-05-23 | 云南师范大学 | Esterase mutant Est8-XL with improved activity and application thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9204439D0 (en) * | 1992-02-27 | 1992-04-15 | Fujisawa Pharmaceutical Co | A new cephalosporin c acylase |
| KR100530299B1 (en) * | 2003-08-11 | 2005-11-22 | 산도즈 게엠베하 | Cephalosporin c acylase mutant and method for preparing 7-aca using same |
| CN102925423B (en) * | 2012-11-16 | 2014-08-06 | 清华大学 | Mutated cephalosporin C acylase |
| CN102978192B (en) * | 2012-12-25 | 2014-09-10 | 湖南福来格生物技术有限公司 | Mutant cephalosporin C acylase, method for preparing same and method for converting 7-aminocephalosporin acid (ACA) |
| KR101728906B1 (en) * | 2013-01-21 | 2017-04-20 | 아미코젠주식회사 | A mutant enzyme for production of cephalosporin antibiotics |
| CN105543201B (en) * | 2016-02-23 | 2018-11-20 | 山西新宝源制药有限公司 | A kind of Cephalosporin C acylase mutant |
| KR101808192B1 (en) * | 2016-08-26 | 2018-01-18 | 아미코젠주식회사 | Methods for preparing recombinant Acremonium chrysogenum producing 7-aminocephalosporanic acid with high concentration and Acremonium chrysogenum prepared thereby |
| CN106432134B (en) * | 2016-09-13 | 2017-10-03 | 山东金城柯瑞化学有限公司 | The method of purification of No. 7 position pendant reactive esters of cynnematin |
| CN106676090B (en) * | 2016-11-09 | 2020-06-02 | 武汉瀚海新酶生物科技有限公司 | Cephalosporin C acylase mutant with improved thermal stability and construction method thereof |
| WO2018165881A1 (en) * | 2017-03-15 | 2018-09-20 | 上海星维生物技术有限公司 | Cephalosporin c acylase mutants and applications thereof |
| CN108220276B (en) * | 2017-10-30 | 2021-05-14 | 南京朗恩生物科技有限公司 | Cephalosporin C acylase mutant and application thereof in 7-aminocephalosporanic acid production |
| CN107653236B (en) * | 2017-10-30 | 2020-03-17 | 南京朗恩生物科技有限公司 | Cephalosporin C acylase mutant and preparation and application thereof |
| CN109576250B (en) * | 2018-12-26 | 2025-04-15 | 广州白云山拜迪生物医药有限公司 | A cephalosporinase mutant with improved enzyme activity and a method for constructing the same |
| CN110129305B (en) * | 2019-05-28 | 2022-10-28 | 河北凯恩利生物技术有限公司 | Cephalosporin C acylase mutant for preparing 7-ACA |
| CN111172142B (en) * | 2020-02-14 | 2021-09-28 | 上海陶宇晟生物技术有限责任公司 | Cephalosporin C acylase mutant with high thermal stability |
-
2020
- 2020-12-29 CN CN202011591118.8A patent/CN112662655B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN112662655A (en) | 2021-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108753669B (en) | Adenine production strain and construction method and application thereof | |
| CN114736879B (en) | Glucose oxidase GoxM10 mutant E361P with improved thermostability and its derivative mutants and applications | |
| CN113862233B (en) | Method for improving acid stability of glucose oxidase, mutant Q241E/R499E, gene and application | |
| CN113151198B (en) | Gamma-glutamine synthetase mutant, coding gene, amino acid sequence and application thereof | |
| WO2017143945A1 (en) | Cephalosporin c acylase mutant | |
| CN109022396B (en) | Alpha-amylase mutant with improved enzyme activity and application thereof | |
| CN112662655B (en) | Cephalosporin C acylase mutant and preparation method and application thereof | |
| CN109943546B (en) | A kind of glutamine transaminase mutant and its preparation method and application | |
| CN112391364B (en) | High-activity glutamine transaminase mutant and preparation method thereof | |
| CN117660428A (en) | Cellobiose 2-epimerase mutant and application thereof in preparation of mannose | |
| CN108004220B (en) | Alkaline protease BmP mutant for improving thermal stability and gene and application thereof | |
| CN111172142B (en) | Cephalosporin C acylase mutant with high thermal stability | |
| CN109072215B (en) | A cephalosporin C acylase mutant and its application | |
| CN114736881B (en) | Glucose oxidase GoxM10 mutant A4D with improved acid stability and its derivative mutants and applications | |
| CN110129305B (en) | Cephalosporin C acylase mutant for preparing 7-ACA | |
| CN105039374A (en) | Starch induction type recombinant bacillus subtilis as well as preparation method and application thereof | |
| CN111471693B (en) | Corynebacterium glutamicum for producing lysine and construction method and application thereof | |
| CN113699087A (en) | Lactobacillus plantarum engineering strain for converting lactose to generate lactulose and construction method and application thereof | |
| CN109913436B (en) | Cephalosporin C acylase mutant containing one or several point mutations and preparation method thereof | |
| CN114957414B (en) | RosR mutant, recombinant microorganism thereof and application thereof | |
| CN114395543B (en) | Trehalose synthase mutant and application thereof | |
| CN112458073B (en) | A kind of H-protein mutant and its application | |
| CN111172143B (en) | D-xylonate dehydratase and its application | |
| CN119432793A (en) | Synthetic Mature Peptide Sequences of HMOs and Their Applications | |
| CN114507273B (en) | YH66_07020 protein and application of related biological material thereof in improving arginine yield |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |